News

Indian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump's executive order.
Nifty Pharma Index saw steep cuts of more than 1.8% in the morning trades on Tuesday amidst Trump Tariff concerns: Aurobindo, ...